Essity AB (publ) (BIT:1ESSI)
Italy · Delayed Price · Currency is EUR | Market Cap | 15.72B -12.3% |
| Revenue (ttm) | 12.46B -6.2% |
| Net Income | 1.14B -0.8% |
| EPS | 1.66 +0.9% |
| Shares Out | n/a |
| PE Ratio | 13.83 |
| Forward PE | 12.59 |
| Dividend | 0.80 (3.50%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | n/a |
| Average Volume | 7 |
| Open | 22.97 |
| Previous Close | 22.97 |
| Day's Range | 22.97 - 22.97 |
| 52-Week Range | 21.52 - 28.00 |
| Beta | n/a |
| RSI | 48.69 |
| Earnings Date | Apr 23, 2026 |
About Essity AB
Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The Health & Medical segment offers incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology under the TENA, Leukoplast, JOBST, Actimove, Cutimed, Delta-Cast, AquaCast Liner, and Hydrofera brands to family carers, prof... [Read more]
Financial Performance
In 2025, Essity AB's revenue was 138.49 billion, a decrease of -4.85% compared to the previous year's 145.55 billion. Earnings were 12.66 billion, a decrease of -39.41%.
Financial numbers in SEK Financial StatementsNews
Essity AB Transcript: CMD 2026
The event outlined a sharpened strategic focus, including a strategic review of the Consumer Tissue business and a shift toward higher value-added segments. Financial targets include >3% organic growth and >15% margin, supported by cost savings, innovation, and increased investment in high-return areas. Business units detailed clear growth strategies and margin ambitions.
Essity AB (ETTYF) Q1 2026 Earnings Call Highlights: Navigating Currency Challenges and ...
Essity AB (ETTYF) Q1 2026 Earnings Call Highlights: Navigating Currency Challenges and Strategic Growth
Q1 2026 Essity AB (publ) Earnings Call Transcript
Q1 2026 Essity AB (publ) Earnings Call Transcript
Essity AB Earnings Call Transcript: Q1 2026
Organic sales and volume growth, improved margins, and strong cash flow marked Q1 2026, supported by a major North American acquisition and a SEK 3 billion share buyback. Input cost inflation and selective price increases are expected to shape results in H2.
Invitation to presentation of Essity's interim report for quarter 1, 2026
STOCKHOLM, March 23, 2026 /PRNewswire/ -- The hygiene and health company, Essity, will publish its interim report for quarter 1, 2026 on April 23 at approximately 07:00 CET. President and CEO Ulrika K...
Essity AB Transcript: UBS Global Consumer and Retail Conference
Strong brands and innovation drive growth in high-margin hygiene and health categories, supported by a decentralized structure and targeted acquisitions. Cost-saving programs and digital transformation underpin efficiency, while disciplined capital allocation supports dividends and buybacks.
Essity AB Earnings Call Transcript: Q4 2025
Profit margins improved across all business areas in Q4 2025, despite negative organic sales growth due to price reductions. Strategic acquisitions, strong cash flow, and product innovation supported market share gains and a proposed 6% dividend increase.
Invitation to presentation of Essity's report for quarter 4 and full year 2025
STOCKHOLM , Dec. 17, 2025 /PRNewswire/ -- The hygiene and health company Essity will publish its report for quarter 4 and full year 2025 on January 22, 2026, at approximately 07:00 CET. President and ...
Essity AB Transcript: M&A Announcement
The acquisition of established feminine care brands in North America for $340 million expands market presence, adds scale, and is expected to deliver $30 million in cost synergies by year two. Management aims to revitalize the brands through innovation and brand building, targeting long-term growth and margin improvement.
Essity AB Earnings Call Transcript: Q3 2025
Organic sales grew 0.9% year-over-year, with record gross margins and profit above SEK 5 billion. A major reorganization and SEK 1 billion cost saving program were announced to accelerate growth, with savings to be reinvested in high-return areas.
Essity: Interim Report Quarter 3, 2025
STOCKHOLM , Oct. 23, 2025 /PRNewswire/ -- Organic growth, higher margin and strong cash flow Quarter 3, 2025 Net sales decreased 4.5% to SEK 34,638m (36,274). Excl. currency translation effects, net s...
Invitation to presentation of Essity's interim report for quarter 3, 2025
STOCKHOLM , Sept. 23, 2025 /PRNewswire/ -- The hygiene and health company Essity will publish its interim report for quarter 3, 2025 on October 23, at approximately 07:00 CET.
Essity AB Transcript: Barclays 18th Annual Global Consumer Staples Conference 2025
The conference highlighted a strategic focus on high-margin segments, innovation, and operational efficiency, with ambitions to outperform market growth and maintain strong financial targets. Leadership emphasized customer centricity, global expansion, and continued M&A, aiming for profitable growth and stability.
Essity AB Earnings Call Transcript: Q2 2025
Organic sales grew 1.9% year-over-year, with strong pricing and innovation offsetting weak volume growth in a challenging market. Profitability was stable but pressured by higher costs, while strategic segments and new product launches drove performance.
Invitation to presentation of Essity's interim report for quarter 2, 2025
STOCKHOLM , June 17, 2025 /PRNewswire/ -- The hygiene and health company Essity will publish its interim report for quarter 2, 2025 on July 17 at approximately 07:00 CET. President and CEO Ulrika Kols...
Essity AB Earnings Call Transcript: Q1 2025
Solid Q1 performance with higher sales, strong cash flow, and flat volumes, driven by price increases and growth in high-margin categories. Tariff impact remains limited, while cost savings and a SEK 3 billion share buyback support a robust outlook for profitable growth.
Interim Report Quarter 1, 2025: Essity
Solid performance with higher sales and strong cash flow STOCKHOLM , April 24, 2025 /PRNewswire/ -- Quarter 1, 2025 Net sales increased 0.4% to SEK 34,976m (34,850) Organic sales growth amounted to 2...
Invitation to presentation of Essity's interim report for quarter 1, 2025
STOCKHOLM , March 24, 2025 /PRNewswire/ -- The hygiene and health company Essity will publish its interim report for quarter 1, 2025 on April 24 at approximately 07:00 CET. President and CEO Magnus Gr...
Essity AB Transcript: UBS Global Consumer and Retail Conference 2025
Strong 2024 results were driven by innovation, portfolio reshaping, and margin expansion. The group targets over 3% organic sales growth and 15%+ margin, with a focus on innovation, M&A in Health & Medical, and expansion in North America and Asia. Share buybacks and rising dividends remain key capital allocation tools.
Essity AB Earnings Call Transcript: Q4 2024
Record 2024 results with SEK 146 billion in sales and over SEK 20 billion operating profit, driven by strong volume growth, innovation, and market share gains. Margins were pressured by higher costs and currency, but cash flow and balance sheet remain robust. Focus for 2025 is on profitable growth, capacity investments, and continued market expansion.
Report for quarter 4 and full-year 2024: Essity
Strong growth in fourth quarter ended a successful 2024 STOCKHOLM , Jan. 23, 2025 /PRNewswire/ -- Quarter 4, 2024 Net sales increased 3.2% to SEK 37,805m (36,625) Organic growth amounted to 3.9%, of ...
Essity AB Transcript: CMD 2024
The company targets over 3% organic sales growth and 15%+ EBITDA margin by focusing on high-margin categories, innovation, and operational excellence. Strong brands, digitalization, and sustainability drive above-market growth, while disciplined capital allocation supports recurring share buybacks and targeted M&A.
Essity AB Earnings Call Transcript: Q3 2024
Profitable growth achieved with higher market shares, strong cash flow, and improved margins. Segment performance was robust, especially in Health & Medical and Consumer Goods, despite headwinds from pulp prices. Share buybacks and sustainability progress highlighted.
Essity: Interim Report, Quarter 3, 2024
STOCKHOLM , Oct. 24, 2024 /PRNewswire/ -- Quarter 3, 2024 - Profitable growth and higher market shares Net sales decreased 2.2% to SEK 36,274m (37,092) Organic growth amounted to 1.9%, of which volume...
Invitation to presentation of Essity's interim report for quarter 3, 2024
STOCKHOLM , Sept. 24, 2024 /PRNewswire/ -- The hygiene and health company Essity will publish its interim report for quarter 3, 2024 on October 24 at approximately 07:00 CET.